SlideShare a Scribd company logo
1 of 11
Download to read offline
1
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Meta-analysis
Abstract
Objective: To perform a systematic review and meta-analysis to comprehensively evaluate
the prognostic role of C-reactive protein (CRP) in Type A acute aortic dissection (AAD).
Methods: PubMed, Web of Science, CNKI, SciELO, and EMBASE were searched until
October 2017 for studies reporting data on the prognostic role of CRP measured at admission
in Type A AAD patients. Inclusion criteria were a diagnosis of Type A AAD, CRP levels
obtained, and a prospective or retrospective cohort study. Relevant outcome data were
extracted, and pooled hazard ratios (HRs) were calculated using a random-effects model.
Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Subgroup analyses by
type of dissection type were carried out.
Results: Of 319 articles identified, 9 (1693 patients) studies met the inclusion criteria and
were included in this meta-analysis. The number of Type A patients ranged from 36 to 570
where elevated CRP was significantly and independently associated with increased risks of
in-hospital mortality in patients with type A - AAD. The results of primary pooled statistics
(n=1693 patients) showed that elevated CRP level was associated with a significantly
increased risk of in-hospital mortality in patients with type AAAD (HR = 1.17, 95%CI: 1.04-
1.33, p =0.01; Table 3 and Figure 1). No heterogeneity was observed among these studies (I2
= 0%; Chi2
:1.21; Cochrane Q, p = 1.00). No publication bias was detected. The pooled
sensitivity of CRP in Type A AAD patients was 77% (95% CI 69%–84%, P < 0.001), and the
specificity was 72% (95% CI 66%–78%, P <0.001).
Conclusion: Elevated CRP level is significantly associated with increased risks of in-hospital
patients with Type A acute aortic dissection. CRP is a convenient prognostic factor in acute
aortic dissection patients.
Keywords: C-reactive protein; Acute aortic dissection; Mortality; Prognosis
Statistical analysis
The extracted data were combined through meta-analysis to calculate a pooled HRs with
95% CIs to assess the prognostic significance of hs-CRP in Type A AAD. An HR >1.0
indicated worse prognosis in patients with elevated CRP levels. Heterogeneity across the
studies was evaluated using the Cochrane's Q and the I2
statistics. A p-value of <0.10 for the
Cochrane's Q test or an I2
value of > 40% indicated significant heterogeneity [39], [40]. A
2
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
random-effects model was used when significant heterogeneity was present [41]; otherwise, a
fixed-effects model was used [40]. Subgroup analyses were conducted by data type, types of
AAD, and adjusted status of HRs. Funnel plot and the Egger’s test were used to evaluate the
risk of publication bias. Stata version 12.0 (STATA Corporation, College Station, TX, USA)
was used for all statistical analyses. A two-sided p value of < 0.05 was considered statistically
significant.
Results
Study selection
A total of 319 potentially eligible studies were identified through the search of the
electronic databases (Figure 1). After reviewing the titles and abstracts, 270 studies were
excluded, and 24 studies were retained for a further detailed evaluation [16]–[19], [27], [28],
[30]–[33], [42]–[54]. Based on the inclusion and exclusion criteria, 16 studies were excluded
[16]–[19], [31], [32], [49]–[54]. Thus, 9 studies, with a total of patients with Type A acute
aortic dissection, were included in this meta-analysis [27]–[30], [33], [43]–[48], [55].
Characteristics of included studies
Table 1 presents the characteristics of the included studies. All nine studies were
published between 2002 to 2017, and the number of patients ranged from 36 to 570. In the
studies, the numbers of patients in the deceased group ranged from 5 to 94 (total = 360), and
the number of patients in the survival group ranged from 31 to 509 (total = 1301). Out of nine
studies, six studies [46]–[48], had NOS score over 6 points while the other three studies [42],
[43], [45] met five points. All included studies were retrospective cohort studies that
examined the CRP level at admission and assessed the prognostic role of at-admission CRP
in Type A AAD patients. Seven studies were performed in China, one in Austria and one in
Croatia. The sample sizes of the studies ranged from 36 to 570, with most studies having
enrolled more than 100 patients. All eight studies reported data on in-hospital mortality [43],
[45], [47], [48]. Eight studies reported unadjusted risk estimates, while five studies only
reported unadjusted risk estimates. CRP values in two [27], [45] study was dealt as a binary
variable, with different cut-off values while six studies presented CRP as continuous variable
[32], [42], [43], [45], [47] (Table 1).
Primary Outcome
The results of primary pooled statistics (n=1693 patients) showed that elevated CRP
level was associated with a significantly increased risk of in-hospital mortality in patients
with type A AAD (HR = 1.17, 95%CI: 1.04-1.33, p =0.01; Table 3 and Figure 1). No
heterogeneity was observed among these studies (I2
= 0%; Chi2
:1.21; Cochrane Q, p = 1.00).
3
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Only eight studies (n = 1442 patients) reported univariate adjusted HRs on the association
between CRP level and in-hospital mortality. Elevated CRP level was associated with a
significantly increased risk of in-hospital mortality in patients with type A acute aortic
dissection (HR =1.27, 95%CI: 1.12-1.45, p =0.0003; Table 4 and Figure 2). No heterogeneity
was observed among these studies (I2
= 0%; 95% Chi2
: 2.30; Cochrane Q, p = 0.94).
Sensitivity and Specificity of CRP in predicting inhospital mortality
All 4 studies provided complete sensitivity and specificity data, and were included in
the analysis. Forest plots summarizing the sensitivity and specificity of CRP levels are shown
in Table 5 and Figure 3, respectively. A random-effects analysis was applied because there
was evidence of heterogeneity among the studies (sensitivity: Heterogeneity chi-squared =
29.54, I2
 = 89.8%, P < 0.001; Table 5 and Figure 3) and (specificity: Heterogeneity chi-squared
= 34.29, I2
 = 91.3%, P < 0.001; Table 6 and Figure 4). The pooled sensitivity of CRP in Type A
AAD patients was 77% (95% CI 69%–84%, P < 0.001), and the specificity was 72% (95% CI
66%–78%, P <0.001). CRP levels were used as continuous variable, and different cut off in
each study but all four studies did have minimum CRP cut off value of ≥9.5, which had
sensitivity 77% and specificity was 72% to predict in-hospital mortality among Type A
patients.
Subgroup Analyses
The results of subgroup analyses were conducted separately for the studies that had CRP
as a continuous and categorical variable. The six studies [32], [42], [43], [45], [47], [48] had
used CRP as continuous variable where elevated CRP level (n=1151 patients) was
significantly associated with an increased risk of in-hospital mortality in patients with type A
AAD (HR = 1.18, 95%CI: 1.02-1.37, p =0.03; Table 7 and Figure 5). No heterogeneity was
observed among these studies (I2
= 0%; Chi2
: 0.57; Cochrane Q, p = 0.99).
Two studies [27], [45] [elevated >6.3 mg/L and ≥12.05 mg/L (categorical)] CRP level as
categorical variable (n=291 patients). However, CRP was not associated with increased risk
of in-hospital mortality in patients with type A AAD (HR = 1.22, 95%CI: 0.93-1.61, p =0.14;
Table 8 and Figure 6). No heterogeneity was observed among these studies (I2
= 0%;
Chi2
=0.24; Cochrane Q, p = 0.63).
Publication bias
To evaluate the risk of publication bias, a funnel plot and Egger’s test was employed. No
obvious publication bias was observed in this meta-analysis in case of association between
high CRP level and in-hospital mortality (p value of eggers?).
4
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Table 1 Characteristics of all studies included in the meta-analysis
Study*Ref.+ Country Design Participants Outcome
(Data type)
Age(y) Men
n(%)
CRP
level
Adjustment NOS
score
Zhou et al.
[48]
China Retrospective 98 patients with
acute type A
aortic dissection
In-hospital
mortality
(H vs L)
55.9±10.3
VS 50.8±9.2
69(70.4) 14.7
(10.5,21.6) VS
5.9 (2.6,10.3)
Yes 6
Li et al.
[47]
China Retrospective 103 patients with
type-A acute6767
aortic dissection
In-hospital
mortality (per unit)
56.5±13.8
VS
53.3±13.2
71(68.9) 9.8±7.8 VS
14.3±10.1
Yes 6
Huang et
al. [43]
China Retrospective 212 consecutive
patients with type
A acute aortic
dissection
In-hospital
mortality (per unit);
Long-term
mortality after a
median follow-up
of 8.8 months (per
unit)
47.7±11.6
VS
51.2±10.7
161(75.9) 30.9 (6.5-85.1)
VS
74.2(8.6-
132.0)
No 5
Fan et al.
[42]
China Retrospective 570 consecutive
patients with type
A aortic
dissection
Long-term
mortality after a
median follow-up
of 1.89 years (per
unit)
46.7±12.7
VS
46.9±10.9
429(75.3) 60.0(56.3-
69.0) VS
52.0 (31.6-
60.9)
No 5
Wen et al.
[46]
China Retrospective 114 patients with
acute aortic
dissection
In-hospital
mortality (H vs L)
48.9±7.6 VS
48.6±7.6
96(84.2) 11.18±1.85 VS
14.08±2.81
Yes 6
Wen et al.
[45]
China Retrospective 36 patients with
acute type A
acute aortic
dissection
In-hospital
mortality (H vs L)
50.6±10.4
VS 67.4±2.3
30(83.3) 11.81±1.87 VS
15.67±5.04
Yes 5
Schillinger
et al. [27]
Austria Retrospective 255 patients with
acute aortic
disease
Long-term
mortality after a
median follow-up
of 50 months (H vs
Median: 66
VS 72
179(70.2) <0.5 to >6.30
in Quartiles
Yes 7
5
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Study*Ref.+ Country Design Participants Outcome
(Data type)
Age(y) Men
n(%)
CRP
level
Adjustment NOS
score
L)
Vrsalovic
et al. [32]
Croatia Retrospective 54 patients with
Type A
CRP has
independent
prognostic value in
type A AAD and
the addition of CRP
to
IRAD score
improved
discriminative
capacity of in-
hospital mortality
irrespective of
symptom duration
and treatment
strategy.
62±12 VS
77±13
34(63.0) 5.0 (2.5-8.5)
VS 15.7 (10.8-
21.4)
No 6
Liu et al
[55].
China Retrospective 251 patients with
Type A
PCT levels
measured in
patients undergoing
Type A aortic
dissection (TAAD)
were used to
determine
prognostic values
for complications
and surgical
outcomes
48.94±12.85
VS
49.67±12.87
197(78.5) 92.82±57.29
VS
128.10±156.80
No 6
(NOS, Newcastle-Ottawa Scale; H vs L, high CRP level versus low CRP level; Mean±SD
6
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Table 2 C-reactive protein Outcomes of the Included Studies
Studies
(Publication year)
Number of
Patients
CRP
Cutoff Value,
(mg/L)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
AUC
Zhou et al. [48] 32 ≥9.5 80 69 56.5 88.5 0.69
Li et al. [47] 36 14 48.9 94.3 81.8 77.8 0.70
Huang et al. [43] 50 na na na na na na
Fan et al. [42] 61 na na na na na na
Wen et al. [46] 31 11.21 100 54.2 44.9 100 0.822
Wen et al. [45] 5 na na na na na na
Vrsalovic et al. [32] 24 >9.8 83 80 76.9 85.7 0.79
Schillinger et al. [27] 94 na na na na na na
Liu et al.[55] 27 na na na na na na
7
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Table 3 Forest plot for CRP levels between Death and Survival (overall, Univariate and
Multivariate)
Figure 1 Funnel plot for CRP levels between Death and Survival
8
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Table 4 Forest plot for CRP levels in univariate Cox regression between Death and
Survival
Figure 2 Funnel plot for CRP levels in univariate Cox regression between Death and
Survival
9
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Table 5 Sensitivity for C reactive protein levels
Study Sensitivity
[95% Conf.
Interval.]
TP/(TP+FN) TN/(TN+FP)
Zhou 2016 0.813 0.636-0.928 26/32 46/66
Li G 2016 0.500 0.329-0.671 18/36 63/67
Wen D 2013 1.000 0.888-1.000 31/31 45/83
Vrsalovic 2015 0.833 0.626-0.953 20/24 24/30
Pooled Sensitivity 0.772 0.688-0.843
Heterogeneity chi-squared = 29.54 (d.f.= 3) p = 0.000
Inconsistency (I-square) = 89.8 %
No. studies = 4.
Figure 3 Forest plot evaluating the sensitivity for C reactive protein levels
Table 6 Specificity for C reactive protein levels
Study Specificity
[95% Conf.
Interval.]
TP/(TP+FN) TN/(TN+FP)
Zhou 2016 0.697 0.571-0.804 26/32 46/66
Li G 2016 0.940 0.854-0.983 18/36 63/67
Wen D 2013 0.542 0.429-0.652 31/31 45/83
Vrsalovic 2015 0.800 0.614-0.923 20/24 24/30
Pooled Sensitivity 0.724 0.663-0.778
Heterogeneity chi-squared = 34.29 (d.f.= 3) p = 0.000
Inconsistency (I-square) = 91.3 %
No. studies = 4.
10
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Figure 4 Forest plot evaluating the specificity for C reactive protein levels
Table 7 Forest plot for Subgroup CRP levels (Continuous) between Death and Survival
Figure 5 Funnel plot for Subgroup CRP levels (Continuous) between Death and Survival
11
Copyright © 2018 Pubrica. No part of this document may be published without permission of the author.
Table 8 Forest plot for Subgroup CRP levels (Categorical) between Death and Survival
Figure 6 Funnel plot for Subgroup CRP levels (Categorical) between Death and Survival
End of the Sample Work
See other sample in www.pubrica.com
Contact Us

More Related Content

What's hot

Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statinEmy Oktaviani
 
Haematology trials 2017
Haematology trials 2017Haematology trials 2017
Haematology trials 2017Fadel Omar
 
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...Bladimir Viloria
 
Semi‑quantitative analysis cerebrospinal fluid chemistry and cellularity using
Semi‑quantitative analysis cerebrospinal fluid chemistry and cellularity usingSemi‑quantitative analysis cerebrospinal fluid chemistry and cellularity using
Semi‑quantitative analysis cerebrospinal fluid chemistry and cellularity usingNeurologyKota
 
Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...
Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...
Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...iosrjce
 
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...Rodrigo Vargas Zapana
 
Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...
Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...
Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...Loan Pham
 
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...inventionjournals
 
Comparison of remission criteria in a tumour necrosis factor inhibitor treate...
Comparison of remission criteria in a tumour necrosis factor inhibitor treate...Comparison of remission criteria in a tumour necrosis factor inhibitor treate...
Comparison of remission criteria in a tumour necrosis factor inhibitor treate...Younis I Munshi
 
Prevalence and predictors of pulmonary arterial hypertension in a sample of i...
Prevalence and predictors of pulmonary arterial hypertension in a sample of i...Prevalence and predictors of pulmonary arterial hypertension in a sample of i...
Prevalence and predictors of pulmonary arterial hypertension in a sample of i...Alexander Decker
 
Assessment of Serum.pdf
Assessment of Serum.pdfAssessment of Serum.pdf
Assessment of Serum.pdfEngTeachSg
 
A quicker tzanck smear with methylene blue stain in diagnosis of
A quicker tzanck smear with methylene blue stain in diagnosis ofA quicker tzanck smear with methylene blue stain in diagnosis of
A quicker tzanck smear with methylene blue stain in diagnosis ofEva Yustiana
 
Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...
Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...
Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...crimsonpublishersOJCHD
 

What's hot (20)

Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statin
 
Haematology trials 2017
Haematology trials 2017Haematology trials 2017
Haematology trials 2017
 
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mende...
 
Bivalirudin and Heparin
Bivalirudin and HeparinBivalirudin and Heparin
Bivalirudin and Heparin
 
Semi‑quantitative analysis cerebrospinal fluid chemistry and cellularity using
Semi‑quantitative analysis cerebrospinal fluid chemistry and cellularity usingSemi‑quantitative analysis cerebrospinal fluid chemistry and cellularity using
Semi‑quantitative analysis cerebrospinal fluid chemistry and cellularity using
 
Resuscitation update by Professor Peter Morley
Resuscitation update by Professor Peter MorleyResuscitation update by Professor Peter Morley
Resuscitation update by Professor Peter Morley
 
Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...
Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...
Correlation between Anti-infliximab and Anti-CCP Antibodies Development in Pa...
 
Digoxina metaanalisis
Digoxina metaanalisisDigoxina metaanalisis
Digoxina metaanalisis
 
International Journal of Proteomics & Bioinformatics
International Journal of Proteomics & BioinformaticsInternational Journal of Proteomics & Bioinformatics
International Journal of Proteomics & Bioinformatics
 
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
 
Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...
Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...
Clinical Trial Simulation to Evaluate the Pharmacokinetics of an Abuse-Deterr...
 
Dores et al
Dores et alDores et al
Dores et al
 
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
 
Comparison of remission criteria in a tumour necrosis factor inhibitor treate...
Comparison of remission criteria in a tumour necrosis factor inhibitor treate...Comparison of remission criteria in a tumour necrosis factor inhibitor treate...
Comparison of remission criteria in a tumour necrosis factor inhibitor treate...
 
Prevalence and predictors of pulmonary arterial hypertension in a sample of i...
Prevalence and predictors of pulmonary arterial hypertension in a sample of i...Prevalence and predictors of pulmonary arterial hypertension in a sample of i...
Prevalence and predictors of pulmonary arterial hypertension in a sample of i...
 
Assessment of Serum.pdf
Assessment of Serum.pdfAssessment of Serum.pdf
Assessment of Serum.pdf
 
A quicker tzanck smear with methylene blue stain in diagnosis of
A quicker tzanck smear with methylene blue stain in diagnosis ofA quicker tzanck smear with methylene blue stain in diagnosis of
A quicker tzanck smear with methylene blue stain in diagnosis of
 
Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...
Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...
Short Term Outcomes after Use of Intracardiac Bone Stem Cell Transplantation ...
 
paper 4
paper 4paper 4
paper 4
 
Curb 65 thorax-2003-lim-377-82
Curb 65 thorax-2003-lim-377-82Curb 65 thorax-2003-lim-377-82
Curb 65 thorax-2003-lim-377-82
 

Similar to Sample Work of an Meta-Analysis | Hire a Meta-Analysis Expert: Pubrica.com

Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...Clinical Surgery Research Communications
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...RahulGupta1687
 
DU PERF SCORING
DU PERF SCORINGDU PERF SCORING
DU PERF SCORINGNHS
 
Journal club edgt 2016 (1)
Journal club edgt 2016 (1)Journal club edgt 2016 (1)
Journal club edgt 2016 (1)sath_gasclub
 
Antibiotic prophylaxis in sever Acute Panceriatitis
Antibiotic prophylaxis in sever Acute PanceriatitisAntibiotic prophylaxis in sever Acute Panceriatitis
Antibiotic prophylaxis in sever Acute PanceriatitisSaeed Al-Shomimi
 
Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...
Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...
Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...asclepiuspdfs
 
Thrombocytosis at time of hospitalization is a reliable 1
Thrombocytosis at time of hospitalization is a reliable 1Thrombocytosis at time of hospitalization is a reliable 1
Thrombocytosis at time of hospitalization is a reliable 1Hesham Abdel Halim
 
PIIS0305737223001603.pdf
PIIS0305737223001603.pdfPIIS0305737223001603.pdf
PIIS0305737223001603.pdfLorenzoMaco
 
The study to measure the level of serum annexin V in patients with renal hype...
The study to measure the level of serum annexin V in patients with renal hype...The study to measure the level of serum annexin V in patients with renal hype...
The study to measure the level of serum annexin V in patients with renal hype...inventionjournals
 
Medical Statistics used in Oncology
Medical Statistics used in OncologyMedical Statistics used in Oncology
Medical Statistics used in OncologyNamrata Das
 
Management of asymptomatic severe aortic stenosis: A review
Management of asymptomatic severe aortic stenosis: A reviewManagement of asymptomatic severe aortic stenosis: A review
Management of asymptomatic severe aortic stenosis: A reviewSirjunRoblesGalura
 
Nejm early goal shock septico 2019
Nejm early goal shock septico 2019Nejm early goal shock septico 2019
Nejm early goal shock septico 2019Lucia Tacanga
 

Similar to Sample Work of an Meta-Analysis | Hire a Meta-Analysis Expert: Pubrica.com (20)

RA-ILD Poster 4-26
RA-ILD Poster 4-26RA-ILD Poster 4-26
RA-ILD Poster 4-26
 
Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...
 
DU PERF SCORING
DU PERF SCORINGDU PERF SCORING
DU PERF SCORING
 
Journal club edgt 2016 (1)
Journal club edgt 2016 (1)Journal club edgt 2016 (1)
Journal club edgt 2016 (1)
 
Antibiotic prophylaxis in sever Acute Panceriatitis
Antibiotic prophylaxis in sever Acute PanceriatitisAntibiotic prophylaxis in sever Acute Panceriatitis
Antibiotic prophylaxis in sever Acute Panceriatitis
 
Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...
Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...
Secondary Malignancy after Treatment of Prostate Cancer. Radical Prostatectom...
 
Thrombocytosis at time of hospitalization is a reliable 1
Thrombocytosis at time of hospitalization is a reliable 1Thrombocytosis at time of hospitalization is a reliable 1
Thrombocytosis at time of hospitalization is a reliable 1
 
PIIS0305737223001603.pdf
PIIS0305737223001603.pdfPIIS0305737223001603.pdf
PIIS0305737223001603.pdf
 
The study to measure the level of serum annexin V in patients with renal hype...
The study to measure the level of serum annexin V in patients with renal hype...The study to measure the level of serum annexin V in patients with renal hype...
The study to measure the level of serum annexin V in patients with renal hype...
 
Medical Statistics used in Oncology
Medical Statistics used in OncologyMedical Statistics used in Oncology
Medical Statistics used in Oncology
 
Management of asymptomatic severe aortic stenosis: A review
Management of asymptomatic severe aortic stenosis: A reviewManagement of asymptomatic severe aortic stenosis: A review
Management of asymptomatic severe aortic stenosis: A review
 
Nejm early goal shock septico 2019
Nejm early goal shock septico 2019Nejm early goal shock septico 2019
Nejm early goal shock septico 2019
 
Hemorrhage
HemorrhageHemorrhage
Hemorrhage
 

More from Pubrica

What are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdfWhat are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdfPubrica
 
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...Pubrica
 
Epidemiological studies that can be conducted in respiratory research?
 Epidemiological studies that can be conducted in respiratory research? Epidemiological studies that can be conducted in respiratory research?
Epidemiological studies that can be conducted in respiratory research?Pubrica
 
Medical case series | Writing services the clinical case report for Scientif...
 Medical case series | Writing services the clinical case report for Scientif... Medical case series | Writing services the clinical case report for Scientif...
Medical case series | Writing services the clinical case report for Scientif...Pubrica
 
Clinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publicationClinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publicationPubrica
 
Research and Scientific Journal Publication support services | Research pape...
 Research and Scientific Journal Publication support services | Research pape... Research and Scientific Journal Publication support services | Research pape...
Research and Scientific Journal Publication support services | Research pape...Pubrica
 
How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis Pubrica
 
Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...Pubrica
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Pubrica
 
Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...Pubrica
 
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...Pubrica
 
A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...Pubrica
 
Cytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticlesCytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticlesPubrica
 
Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...Pubrica
 
What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...Pubrica
 
Addressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdfAddressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdfPubrica
 
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...Pubrica
 
Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...Pubrica
 
Data gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchainData gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchainPubrica
 
Narrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extractionNarrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extractionPubrica
 

More from Pubrica (20)

What are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdfWhat are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdf
 
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
 
Epidemiological studies that can be conducted in respiratory research?
 Epidemiological studies that can be conducted in respiratory research? Epidemiological studies that can be conducted in respiratory research?
Epidemiological studies that can be conducted in respiratory research?
 
Medical case series | Writing services the clinical case report for Scientif...
 Medical case series | Writing services the clinical case report for Scientif... Medical case series | Writing services the clinical case report for Scientif...
Medical case series | Writing services the clinical case report for Scientif...
 
Clinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publicationClinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publication
 
Research and Scientific Journal Publication support services | Research pape...
 Research and Scientific Journal Publication support services | Research pape... Research and Scientific Journal Publication support services | Research pape...
Research and Scientific Journal Publication support services | Research pape...
 
How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis
 
Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...
 
Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...
 
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
 
A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...
 
Cytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticlesCytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticles
 
Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...
 
What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...
 
Addressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdfAddressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdf
 
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
 
Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...
 
Data gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchainData gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchain
 
Narrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extractionNarrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extraction
 

Recently uploaded

Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Call Girls Service Chandigarh Ayushi
 
Dehradun Call Girls Service 8854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 8854095900 Real Russian Girls Looking ModelsDehradun Call Girls Service 8854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 8854095900 Real Russian Girls Looking Modelsindiancallgirl4rent
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...Gfnyt
 
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅gragmanisha42
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...Call Girls Noida
 
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girls Service Chandigarh Ayushi
 
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in UdaipurUdaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipurseemahedar019
 
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girls Service Gurgaon
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Call Girls Noida
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near MeVIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Memriyagarg453
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliHigh Profile Call Girls Chandigarh Aarushi
 
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591adityaroy0215
 

Recently uploaded (20)

#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
 
Dehradun Call Girls Service 8854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 8854095900 Real Russian Girls Looking ModelsDehradun Call Girls Service 8854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 8854095900 Real Russian Girls Looking Models
 
Call Girl Lucknow Gauri 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girl Lucknow Gauri 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girl Lucknow Gauri 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girl Lucknow Gauri 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
 
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
 
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
 
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
 
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in UdaipurUdaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
 
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
 
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
 
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service DehradunCall Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near MeVIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
 
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
 

Sample Work of an Meta-Analysis | Hire a Meta-Analysis Expert: Pubrica.com

  • 1. 1 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Meta-analysis Abstract Objective: To perform a systematic review and meta-analysis to comprehensively evaluate the prognostic role of C-reactive protein (CRP) in Type A acute aortic dissection (AAD). Methods: PubMed, Web of Science, CNKI, SciELO, and EMBASE were searched until October 2017 for studies reporting data on the prognostic role of CRP measured at admission in Type A AAD patients. Inclusion criteria were a diagnosis of Type A AAD, CRP levels obtained, and a prospective or retrospective cohort study. Relevant outcome data were extracted, and pooled hazard ratios (HRs) were calculated using a random-effects model. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Subgroup analyses by type of dissection type were carried out. Results: Of 319 articles identified, 9 (1693 patients) studies met the inclusion criteria and were included in this meta-analysis. The number of Type A patients ranged from 36 to 570 where elevated CRP was significantly and independently associated with increased risks of in-hospital mortality in patients with type A - AAD. The results of primary pooled statistics (n=1693 patients) showed that elevated CRP level was associated with a significantly increased risk of in-hospital mortality in patients with type AAAD (HR = 1.17, 95%CI: 1.04- 1.33, p =0.01; Table 3 and Figure 1). No heterogeneity was observed among these studies (I2 = 0%; Chi2 :1.21; Cochrane Q, p = 1.00). No publication bias was detected. The pooled sensitivity of CRP in Type A AAD patients was 77% (95% CI 69%–84%, P < 0.001), and the specificity was 72% (95% CI 66%–78%, P <0.001). Conclusion: Elevated CRP level is significantly associated with increased risks of in-hospital patients with Type A acute aortic dissection. CRP is a convenient prognostic factor in acute aortic dissection patients. Keywords: C-reactive protein; Acute aortic dissection; Mortality; Prognosis Statistical analysis The extracted data were combined through meta-analysis to calculate a pooled HRs with 95% CIs to assess the prognostic significance of hs-CRP in Type A AAD. An HR >1.0 indicated worse prognosis in patients with elevated CRP levels. Heterogeneity across the studies was evaluated using the Cochrane's Q and the I2 statistics. A p-value of <0.10 for the Cochrane's Q test or an I2 value of > 40% indicated significant heterogeneity [39], [40]. A
  • 2. 2 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. random-effects model was used when significant heterogeneity was present [41]; otherwise, a fixed-effects model was used [40]. Subgroup analyses were conducted by data type, types of AAD, and adjusted status of HRs. Funnel plot and the Egger’s test were used to evaluate the risk of publication bias. Stata version 12.0 (STATA Corporation, College Station, TX, USA) was used for all statistical analyses. A two-sided p value of < 0.05 was considered statistically significant. Results Study selection A total of 319 potentially eligible studies were identified through the search of the electronic databases (Figure 1). After reviewing the titles and abstracts, 270 studies were excluded, and 24 studies were retained for a further detailed evaluation [16]–[19], [27], [28], [30]–[33], [42]–[54]. Based on the inclusion and exclusion criteria, 16 studies were excluded [16]–[19], [31], [32], [49]–[54]. Thus, 9 studies, with a total of patients with Type A acute aortic dissection, were included in this meta-analysis [27]–[30], [33], [43]–[48], [55]. Characteristics of included studies Table 1 presents the characteristics of the included studies. All nine studies were published between 2002 to 2017, and the number of patients ranged from 36 to 570. In the studies, the numbers of patients in the deceased group ranged from 5 to 94 (total = 360), and the number of patients in the survival group ranged from 31 to 509 (total = 1301). Out of nine studies, six studies [46]–[48], had NOS score over 6 points while the other three studies [42], [43], [45] met five points. All included studies were retrospective cohort studies that examined the CRP level at admission and assessed the prognostic role of at-admission CRP in Type A AAD patients. Seven studies were performed in China, one in Austria and one in Croatia. The sample sizes of the studies ranged from 36 to 570, with most studies having enrolled more than 100 patients. All eight studies reported data on in-hospital mortality [43], [45], [47], [48]. Eight studies reported unadjusted risk estimates, while five studies only reported unadjusted risk estimates. CRP values in two [27], [45] study was dealt as a binary variable, with different cut-off values while six studies presented CRP as continuous variable [32], [42], [43], [45], [47] (Table 1). Primary Outcome The results of primary pooled statistics (n=1693 patients) showed that elevated CRP level was associated with a significantly increased risk of in-hospital mortality in patients with type A AAD (HR = 1.17, 95%CI: 1.04-1.33, p =0.01; Table 3 and Figure 1). No heterogeneity was observed among these studies (I2 = 0%; Chi2 :1.21; Cochrane Q, p = 1.00).
  • 3. 3 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Only eight studies (n = 1442 patients) reported univariate adjusted HRs on the association between CRP level and in-hospital mortality. Elevated CRP level was associated with a significantly increased risk of in-hospital mortality in patients with type A acute aortic dissection (HR =1.27, 95%CI: 1.12-1.45, p =0.0003; Table 4 and Figure 2). No heterogeneity was observed among these studies (I2 = 0%; 95% Chi2 : 2.30; Cochrane Q, p = 0.94). Sensitivity and Specificity of CRP in predicting inhospital mortality All 4 studies provided complete sensitivity and specificity data, and were included in the analysis. Forest plots summarizing the sensitivity and specificity of CRP levels are shown in Table 5 and Figure 3, respectively. A random-effects analysis was applied because there was evidence of heterogeneity among the studies (sensitivity: Heterogeneity chi-squared = 29.54, I2  = 89.8%, P < 0.001; Table 5 and Figure 3) and (specificity: Heterogeneity chi-squared = 34.29, I2  = 91.3%, P < 0.001; Table 6 and Figure 4). The pooled sensitivity of CRP in Type A AAD patients was 77% (95% CI 69%–84%, P < 0.001), and the specificity was 72% (95% CI 66%–78%, P <0.001). CRP levels were used as continuous variable, and different cut off in each study but all four studies did have minimum CRP cut off value of ≥9.5, which had sensitivity 77% and specificity was 72% to predict in-hospital mortality among Type A patients. Subgroup Analyses The results of subgroup analyses were conducted separately for the studies that had CRP as a continuous and categorical variable. The six studies [32], [42], [43], [45], [47], [48] had used CRP as continuous variable where elevated CRP level (n=1151 patients) was significantly associated with an increased risk of in-hospital mortality in patients with type A AAD (HR = 1.18, 95%CI: 1.02-1.37, p =0.03; Table 7 and Figure 5). No heterogeneity was observed among these studies (I2 = 0%; Chi2 : 0.57; Cochrane Q, p = 0.99). Two studies [27], [45] [elevated >6.3 mg/L and ≥12.05 mg/L (categorical)] CRP level as categorical variable (n=291 patients). However, CRP was not associated with increased risk of in-hospital mortality in patients with type A AAD (HR = 1.22, 95%CI: 0.93-1.61, p =0.14; Table 8 and Figure 6). No heterogeneity was observed among these studies (I2 = 0%; Chi2 =0.24; Cochrane Q, p = 0.63). Publication bias To evaluate the risk of publication bias, a funnel plot and Egger’s test was employed. No obvious publication bias was observed in this meta-analysis in case of association between high CRP level and in-hospital mortality (p value of eggers?).
  • 4. 4 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Table 1 Characteristics of all studies included in the meta-analysis Study*Ref.+ Country Design Participants Outcome (Data type) Age(y) Men n(%) CRP level Adjustment NOS score Zhou et al. [48] China Retrospective 98 patients with acute type A aortic dissection In-hospital mortality (H vs L) 55.9±10.3 VS 50.8±9.2 69(70.4) 14.7 (10.5,21.6) VS 5.9 (2.6,10.3) Yes 6 Li et al. [47] China Retrospective 103 patients with type-A acute6767 aortic dissection In-hospital mortality (per unit) 56.5±13.8 VS 53.3±13.2 71(68.9) 9.8±7.8 VS 14.3±10.1 Yes 6 Huang et al. [43] China Retrospective 212 consecutive patients with type A acute aortic dissection In-hospital mortality (per unit); Long-term mortality after a median follow-up of 8.8 months (per unit) 47.7±11.6 VS 51.2±10.7 161(75.9) 30.9 (6.5-85.1) VS 74.2(8.6- 132.0) No 5 Fan et al. [42] China Retrospective 570 consecutive patients with type A aortic dissection Long-term mortality after a median follow-up of 1.89 years (per unit) 46.7±12.7 VS 46.9±10.9 429(75.3) 60.0(56.3- 69.0) VS 52.0 (31.6- 60.9) No 5 Wen et al. [46] China Retrospective 114 patients with acute aortic dissection In-hospital mortality (H vs L) 48.9±7.6 VS 48.6±7.6 96(84.2) 11.18±1.85 VS 14.08±2.81 Yes 6 Wen et al. [45] China Retrospective 36 patients with acute type A acute aortic dissection In-hospital mortality (H vs L) 50.6±10.4 VS 67.4±2.3 30(83.3) 11.81±1.87 VS 15.67±5.04 Yes 5 Schillinger et al. [27] Austria Retrospective 255 patients with acute aortic disease Long-term mortality after a median follow-up of 50 months (H vs Median: 66 VS 72 179(70.2) <0.5 to >6.30 in Quartiles Yes 7
  • 5. 5 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Study*Ref.+ Country Design Participants Outcome (Data type) Age(y) Men n(%) CRP level Adjustment NOS score L) Vrsalovic et al. [32] Croatia Retrospective 54 patients with Type A CRP has independent prognostic value in type A AAD and the addition of CRP to IRAD score improved discriminative capacity of in- hospital mortality irrespective of symptom duration and treatment strategy. 62±12 VS 77±13 34(63.0) 5.0 (2.5-8.5) VS 15.7 (10.8- 21.4) No 6 Liu et al [55]. China Retrospective 251 patients with Type A PCT levels measured in patients undergoing Type A aortic dissection (TAAD) were used to determine prognostic values for complications and surgical outcomes 48.94±12.85 VS 49.67±12.87 197(78.5) 92.82±57.29 VS 128.10±156.80 No 6 (NOS, Newcastle-Ottawa Scale; H vs L, high CRP level versus low CRP level; Mean±SD
  • 6. 6 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Table 2 C-reactive protein Outcomes of the Included Studies Studies (Publication year) Number of Patients CRP Cutoff Value, (mg/L) Sensitivity (%) Specificity (%) PPV (%) NPV (%) AUC Zhou et al. [48] 32 ≥9.5 80 69 56.5 88.5 0.69 Li et al. [47] 36 14 48.9 94.3 81.8 77.8 0.70 Huang et al. [43] 50 na na na na na na Fan et al. [42] 61 na na na na na na Wen et al. [46] 31 11.21 100 54.2 44.9 100 0.822 Wen et al. [45] 5 na na na na na na Vrsalovic et al. [32] 24 >9.8 83 80 76.9 85.7 0.79 Schillinger et al. [27] 94 na na na na na na Liu et al.[55] 27 na na na na na na
  • 7. 7 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Table 3 Forest plot for CRP levels between Death and Survival (overall, Univariate and Multivariate) Figure 1 Funnel plot for CRP levels between Death and Survival
  • 8. 8 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Table 4 Forest plot for CRP levels in univariate Cox regression between Death and Survival Figure 2 Funnel plot for CRP levels in univariate Cox regression between Death and Survival
  • 9. 9 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Table 5 Sensitivity for C reactive protein levels Study Sensitivity [95% Conf. Interval.] TP/(TP+FN) TN/(TN+FP) Zhou 2016 0.813 0.636-0.928 26/32 46/66 Li G 2016 0.500 0.329-0.671 18/36 63/67 Wen D 2013 1.000 0.888-1.000 31/31 45/83 Vrsalovic 2015 0.833 0.626-0.953 20/24 24/30 Pooled Sensitivity 0.772 0.688-0.843 Heterogeneity chi-squared = 29.54 (d.f.= 3) p = 0.000 Inconsistency (I-square) = 89.8 % No. studies = 4. Figure 3 Forest plot evaluating the sensitivity for C reactive protein levels Table 6 Specificity for C reactive protein levels Study Specificity [95% Conf. Interval.] TP/(TP+FN) TN/(TN+FP) Zhou 2016 0.697 0.571-0.804 26/32 46/66 Li G 2016 0.940 0.854-0.983 18/36 63/67 Wen D 2013 0.542 0.429-0.652 31/31 45/83 Vrsalovic 2015 0.800 0.614-0.923 20/24 24/30 Pooled Sensitivity 0.724 0.663-0.778 Heterogeneity chi-squared = 34.29 (d.f.= 3) p = 0.000 Inconsistency (I-square) = 91.3 % No. studies = 4.
  • 10. 10 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Figure 4 Forest plot evaluating the specificity for C reactive protein levels Table 7 Forest plot for Subgroup CRP levels (Continuous) between Death and Survival Figure 5 Funnel plot for Subgroup CRP levels (Continuous) between Death and Survival
  • 11. 11 Copyright © 2018 Pubrica. No part of this document may be published without permission of the author. Table 8 Forest plot for Subgroup CRP levels (Categorical) between Death and Survival Figure 6 Funnel plot for Subgroup CRP levels (Categorical) between Death and Survival End of the Sample Work See other sample in www.pubrica.com Contact Us